your badges 52W Range $13–$31 46% of range Analyst Rating HOLD 6 analysts Price Target $19 P/E -69.3 ROE -5.4% Net Profit Margin -26.0%

FLGT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $21.48
Market Cap (MRQ) $591M
P/E -69.3
Revenue $323M
ROE -5.4%
Debt/Equity (MRQ) 0.0
52W Range $13–$31

FLGT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Fulgent Genetics, Inc. - Common Stock Company overview from Wikipedia

05 · wikidata
sectorHealth Care industryHealth Care employees1,315 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$323M
2016-12-31 → 2025-12-31
Free Cash Flow$-124M
2016-12-31 → 2025-12-31
Net margin-26.0%
2016-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend FLGT 5Y avg Peer Median Verdict
P/E -69.35Y avg ≈-131.6 ≈-131.6 · ·
P/S (TTM) 1.85Y avg ≈2.4 ≈2.4 1.9 Fair value
P/B (MRQ) 0.65Y avg ≈1.1 ≈1.1 1.7 Undervalued
EV / EBITDA -9.25Y avg ≈-3.7 ≈-3.7 · ·
Price / FCF (TTM) -5.75Y avg ≈30.4 ≈30.4 · ·
Price / Cash Flow (TTM) -7.15Y avg ≈12.0 ≈12.0 · ·
EV / Revenue 1.95Y avg ≈2.2 ≈2.2 · ·
EV / FCF -5.05Y avg ≈27.0 ≈27.0 · ·
Price / Tangible Book (MRQ) 0.75Y avg ≈1.2 ≈1.2 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -12.6%
Next Report Nov 05, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 30, 2026 $-0.58 $-0.47 -23.6%
March 31, 2026 $-0.36 $-0.11 -236.1%
Dec. 31, 2025 $-0.36 $-0.11 -236.1%
Sept. 30, 2025 $0.14 $-0.23 161.5%
June 30, 2025 $0.07 $-0.19 137.4%
March 31, 2025 $0.04 $-0.19 121.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 20252024202320222021202020192018201720162015
Revenue $323M$283M$289M$619M$993M$422M$33M$21M$19M$18M$10M
Cost of Revenue $192M$176M$185M$252M$216M$90M$14M$0$9M$7M$5M
Gross Profit $131M$107M$104M$367M$777M$332M$18M$11M$10M$12M$5M
R&D Expense $54M$49M$41M$29M$24M$12M$7M$6M$4M$4M$4M
SG&A Expense $117M$88M$89M$111M$51M$15M$6M$6M$5M$5M$2M
Operating Expenses $222M$181M$300M$188M$101M$42M$19M$16M$14M$11M$10M
Operating Income $-91M$-74M$-196M$179M$676M$290M$-428.0K$-5M$-3M$918.0K$-5M
Interest Expense ···$346.0K$117.0K$20.0K·····
Interest Income $31M$31M$22M$6M·······
Other Non-op $153.0K$561.0K$320.0K$887.0K·······
Pretax Income $-70M$-52M$-174M$184M$677M$292M$409.0K$-5M$-3M$-4M$-5M
Income Tax $-8M$-8M$1M$42M$175M$73M$43.0K$36.0K$-1M$920.0K$0
Net Income $-61M$-43M$-168M$143M$507M$214M$-411.0K$-6M$-3M$-5M$-8M
Shares (Basic) 30,777,00030,235,00029,784,00030,097,00029,408,00022,694,00018,709,00017,978,00017,739,000··
Shares (Diluted) 30,777,00030,235,00029,784,00030,964,00030,976,00024,056,00018,709,00017,978,00017,739,000··
EBITDA $-67M$-49M$-169M$211M$687M$290M$-428.0K$-5M$-3M$918.0K·
Balance Sheet 29
Metric Trend 20252024202320222021202020192018201720162015
Cash & Equivalents $50M$55M$97M$80M$165M$87M$12M$7M$6M$8M$489.0K
Short-term Investments ········$20M$13M·
Receivables $85M$69M$51M$53M$139M$184M$7M$6M$4M$4M$2M
Prepaid Expense $5M$7M$8M$7M$4M$4M$1M$556.0K$624.0K$375.0K$65.0K
Other Current Assets $23M$23M$33M$49M$23M$40M$2M$3M$2M$906.0K$314.0K
Current Assets $550M$354M$508M$628M$612M$524M$37M$40M$33M$26M$3M
PP&E (Net) $113M$106M$83M$81M$62M$40M$6M$6M$7M$6M$2M
PP&E (Gross) $170M$157M$135M$125M$82M$51M$14M$12M$11M$8M$3M
Accum. Depreciation $58M$52M$52M$43M$20M$11M$8M$6M$4M$2M$900.0K
Goodwill $25M$22M$22M$143M$51M······
Intangibles $133M$135M$143M$151M$36M······
Other Non-current Assets $23M$33M$35M$44M$11M$4M$251.0K$17.0K$39.0K$17.0K·
Total Assets $1.21B$1.22B$1.24B$1.39B$1.28B$700M$89M$54M$57M$58M$6M
Accounts Payable $19M$18M$15M$23M$20M$26M$2M$1M$2M$3M$314.0K
Accrued Liabilities $34M$24M$31M$25M$18M$8M$1M$1M$911.0K$436.0K$199.0K
Short-term Debt $476.0K$412.0K$1M$6M$6M······
Current Liabilities $85M$73M$73M$88M$105M$130M$4M$3M$3M$3M$686.0K
Capital Leases $4M$4M$7M$9M$5M$568.0K$2M····
Deferred Tax $7M$6M$8M······$243.0K·
Other Non-current Liabilities $8M$7M$15M$18M$7M$582.0K·$14.0K$6.0K$2.0K·
Total Liabilities $107M$91M$102M$116M$113M$131M$6M$3M$3M$4M$686.0K
Total Debt $476.0K$412.0K$1M$6M$6M······
Common Stock $3.0K$3.0K$3.0K$3.0K$3.0K$3.0K$2.0K$2.0K$2.0K$2.0K·
Paid-in Capital ·········$110M·
Retained Earnings $530M$590M$633M$801M$658M$151M$-63M$-63M$-58M$-55M$-53M
AOCI $8M$-368.0K$1M$-21M$-759.0K$438.0K$146.0K$-35.0K$-44.0K$-103.0K·
Stockholders' Equity $1.11B$1.13B$1.14B$1.27B$1.16B$569M$83M$51M$54M$54M$5M
Liabilities + Equity $1.21B$1.22B$1.24B$1.39B$1.28B$700M$89M$54M$57M$58M$6M
Shares Outstanding 31,081,00030,841,00029,653,00029,438,00030,160,00028,178,00021,483,00018,172,00017,847,00017,676,000·
Cash Flow 16
Metric Trend 20252024202320222021202020192018201720162015
D&A $24M$25M$26M$33M$11M$3M$2M·$2M$1M$575.0K
Stock-based Comp $40M$44M$43M$33M$16M$8M$3M$2M$2M$5M$8M
Deferred Tax $-1M$-4M$11M$-8M$-8M$-2M$-21.0K$36.0K$-336.0K$246.0K·
Amort. of Intangibles $8M$8M$8M$6M$2M······
Other Non-cash $-104M$-2M$114M$53M$13M······
Operating Cash Flow $-102M$21M$27M$254M$539M$141M$6M$-675.0K$1M$4M$-969.0K
CapEx $23M$40M$22M$19M$24M$35M$1M$2M$3M$4M$2M
Investing Cash Flow $111M$-58M$39M$-261M$-547M$-326M$-29M$950.0K$-2M$-43M$-2M
Stock Issued ····$89M$246M$29M··$37M·
Stock Repurchased $11M$225.0K$25M$74M·$62.0K$21.0K····
Net Stock Activity $-11M$-225.0K$-25M$-74M$89M$246M$29M··$37M·
Financing Cash Flow $-15M$-5M$-48M$-77M$85M$261M$29M$15.0K$-770.0K$46M$4M
Net Change in Cash $-5M$-42M$18M$-85M$77M$75M$5M$246.0K$-1M··
Taxes Paid $96M··········
Free Cash Flow $-124M$-19M$5M$235M$515M$105M$4M$-3M$-2M$617.0K·
Levered FCF ···$234M$515M$105M·····
Profitability 8
Metric Trend 20252024202320222021202020192018201720162015
Gross Margin 40.6%37.8%36.1%59.3%78.3%78.7%56.6%49.9%54.4%63.2%·
Operating Margin -28.2%-26.1%-67.6%28.8%68.1%68.8%-1.3%-23.8%-18.6%5.0%·
Net Margin -18.8%-15.1%-58.0%23.2%51.1%50.8%-1.3%-26.3%-13.4%-29.3%·
Pretax Margin -21.7%-18.3%-60.2%29.7%68.2%69.2%1.3%-21.7%-16.0%-24.4%·
EBITDA Margin -20.8%-17.3%-58.6%34.1%69.2%68.8%-1.3%-23.8%-18.6%5.0%·
ROA -5.0%-3.5%-12.8%10.8%51.3%54.3%-0.58%-10.1%-4.4%-16.7%·
ROE -5.4%-3.8%-14.0%11.8%58.7%65.3%-0.60%-10.8%-4.6%-17.9%·
ROIC -7.2%-5.5%-17.3%10.8%43.0%38.3%-0.46%-10.0%-4.2%2.0%·
Liquidity & Solvency 4
Metric Trend 20252024202320222021202020192018201720162015
Current Ratio 6.54.97.07.15.84.010.014.411.07.9·
Quick Ratio 1.61.72.01.52.92.15.04.610.27.6·
Debt / Equity 0.00.00.00.00.0······
Interest Coverage ···516.05777.414507.9·····
Efficiency 2
Metric Trend 20252024202320222021202020192018201720162015
Asset Turnover 0.30.20.20.51.01.10.50.40.30.6·
Receivables Turnover 4.24.75.66.56.24.45.24.34.55.6·
Per Share 5
Metric Trend 20252024202320222021202020192018201720162015
Book Value / Share $35.78$36.74$38.31$43.03$38.42$20.21$3.85$2.81$3.04$3.08·
Revenue / Share $10.48$9.38$9.71$19.99$32.04$17.53$1.74$1.19···
Cash Flow / Share $-3.30$0.70$0.91$8.19$17.39$5.85$0.29$-0.04···
Cash / Share $1.61$1.79$3.29$2.70$5.47$3.10$0.56$0.37$0.36$0.45·
EPS (TTM) $-0.31$-0.31$-0.31$-0.31$-0.31$-0.31$-0.31$-0.31$-0.14$-5.90·
Growth Rates 4
Metric Trend 20252024202320222021202020192018201720162015
Revenue YoY 13.8%-2.0%-53.3%-37.6%135.4%······
Revenue CAGR 3Y -19.5%-34.2%-11.8%········
Revenue CAGR 5Y -5.2%··········
Net Income YoY ···-71.7%136.7%······
Valuation (TTM) 14
Metric Trend 20252024202320222021202020192018201720162015
Revenue TTM $323M$283M$289M$619M$993M$422M$33M$21M$19M$18M·
Net Income TTM $-61M$-43M$-168M$143M$507M$214M$-411.0K$-6M$-3M$-5M·
Market Cap $816M$570M$857M$877M$3.03B$1.47B$277M$58M$78M$205M·
Enterprise Value $767M$515M$761M$803M$2.88B······
P/E -84.7-59.6-93.3-96.1-324.5-168.1-41.6-10.2-31.3-2.0·
P/S 2.52.03.01.43.13.58.52.74.211.2·
P/B 0.70.50.80.72.62.63.31.11.43.8·
P / Tangible Book 0.90.60.90.92.82.6·····
P / Cash Flow -8.027.031.73.55.610.450.2-85.358.746.4·
P / FCF -6.6-29.6178.73.75.913.963.9-19.2-50.0331.5·
EV / EBITDA -11.4-10.5-4.53.84.2······
EV / FCF -6.2-26.7158.73.45.6······
EV / Revenue 2.41.82.61.32.9······
Earnings Yield -1.2%-1.7%-1.1%-1.0%-0.31%-0.60%-2.4%-9.8%-3.2%-51.0%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $323M $283M $289M $619M $993M
Gross Margin % 40.6% 37.8% 36.1% 59.3% 78.3%
Operating Margin % -28.2% -26.1% -67.6% 28.8% 68.1%
Net Income $-61M $-43M $-168M $143M $507M

Institutional owners (13F) 157 filers · $343.3M total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 157
Value held $343.3M
New positions 22
Exited positions 36
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
22 (-11 vs prior Q) 36 (-7 vs prior Q) 38 (-6 vs prior Q) 54 (-2 vs prior Q) -1.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BlackRock, Inc. $46,922,448 2,286,669 13.67% Shares
VANGUARD GROUP INC $33,100,568 1,260,014 9.64% Shares
VANGUARD CAPITAL MANAGEMENT LLC $16,200,499 789,498 4.72% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $16,049,020 782,116 4.68% Shares
JPMORGAN CHASE & CO $15,532,135 756,558 4.52% Shares
Diametric Capital, LP $14,318,527 697,784 4.17% Shares
AMERIPRISE FINANCIAL INC $13,750,124 670,084 4.01% Shares
DIMENSIONAL FUND ADVISORS LP $12,832,302 625,355 3.74% Shares
GEODE CAPITAL MANAGEMENT, LLC $10,693,721 521,014 3.12% Shares
STATE STREET CORP $10,232,770 498,673 2.98% Shares
Invenomic Capital Management LP $10,224,849 498,287 2.98% Shares
TWO SIGMA INVESTMENTS, LP $8,228,233 400,986 2.40% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $7,202,253 350,987 2.10% Shares
MILLENNIUM MANAGEMENT LLC $6,585,073 320,910 1.92% Shares
GOLDMAN SACHS GROUP INC $6,318,929 307,940 1.84% Shares
D. E. Shaw & Co., Inc. $5,991,963 292,006 1.75% Shares
TWO SIGMA ADVISERS, LP $5,083,245 193,500 1.48% Shares
Peapod Lane Capital LLC $4,600,728 224,207 1.34% Shares
Point72 Asset Management, L.P. $4,344,248 211,708 1.27% Shares
Medina Value Partners, LLC $3,961,612 193,061 1.15% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $3,823,102 186,311 1.11% Shares
BANK OF AMERICA CORP /DE/ $3,602,922 175,581 1.05% Shares
UBS Group AG $3,590,015 174,952 1.05% Shares
CITADEL ADVISORS LLC $3,574,174 174,180 1.04% Shares
NORTHERN TRUST CORP $3,488,769 170,018 1.02% Shares
Brandywine Global Investment Management, LLC $3,289,267 125,210 0.96% Shares
MORGAN STANLEY $3,272,318 159,469 0.95% Shares
Connor, Clark & Lunn Investment Management Ltd. $3,264,896 159,108 0.95% Shares
Allianz Asset Management GmbH $3,171,920 154,577 0.92% Shares
Cubist Systematic Strategies, LLC $2,774,150 122,750 0.81% Shares
Russell Investments Group, Ltd. $2,773,188 135,138 0.81% Shares
TCW GROUP INC $2,696,328 131,400 0.79% Shares
VANGUARD FIDUCIARY TRUST CO $2,594,036 126,415 0.76% Shares
Quantinno Capital Management LP $2,368,131 115,406 0.69% Shares
Jump Financial, LLC $2,242,836 109,300 0.65% Shares
LEVIN CAPITAL STRATEGIES, L.P. $2,165,722 105,542 0.63% Shares
Almitas Capital LLC $2,150,434 104,797 0.63% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,816,020 88,500 0.53% Call option
TUDOR INVESTMENT CORP ET AL $1,677,038 81,727 0.49% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $1,610,717 101,303 0.47% Shares
Bank of New York Mellon Corp $1,552,103 75,639 0.45% Shares
AQR CAPITAL MANAGEMENT LLC $1,425,176 69,453 0.42% Shares
Nuveen, LLC $1,369,198 66,725 0.40% Shares
BNP PARIBAS FINANCIAL MARKETS $1,274,066 62,089 0.37% Shares
CAXTON ASSOCIATES LLP $1,273,656 62,069 0.37% Shares
WELLS FARGO & COMPANY/MN $1,217,760 59,345 0.35% Shares
CITIGROUP INC $1,154,168 56,246 0.34% Shares
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $1,133,668 55,247 0.33% Shares
Balyasny Asset Management L.P. $1,119,756 54,569 0.33% Shares
Invesco Ltd. $1,076,951 52,483 0.31% Shares

Show all 157 institutional owners →

Activists & 5%+ owners 3 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Ming Hsieh, The Ming Hsieh Trust ×7 filings May 27, 2026 32.26% Amendment Passive investment SEC
Han Lin Gao ×2 filings Sept. 17, 2020 · Initial filing Passive investment SEC
Han Lin Gao (2) Sept. 13, 2019 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 13 insiders · 4 officers · 9 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Ming Hsieh Chief Executive Officer Sept. 1, 2026 F 885,952 0 0 $0
Paul Kim CFO and Treasurer Sept. 1, 2026 F 356,543 0 0 $0
Jian Xie President and COO Sept. 2, 2026 S 359,924 0 8 $-504,571
Hanlin Gao Chief Scientific Officer Sept. 2, 2026 S 986,117 0 7 $-173,057
Michael Nohaile Director May 14, 2026 A 24,578 0 0 $0
Linda Dong Director May 14, 2026 A 38,758 0 0 $0
Regina E Groves Director May 14, 2026 A 28,099 0 0 $0
Leonard E Post Director Aug. 1, 2022 A 8,000 0 0 $0
John C Bolger Director Aug. 1, 2022 A 5,100 0 0 $0
Yun Yen Director May 18, 2022 A 2,000 0 0 $0
James Mulay Director May 30, 2019 A 10,000 0 0 $0
Fulgent Genetics, Inc. Director May 16, 2017 A 10,000 0 0 $0
Xi Long USA, Inc. 10% owner Sept. 30, 2016 J 2,025,623 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 22 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IHF · iShares Trust 0.06% 36,037 SH Sept. 11, 2026 Daily
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0.05% 16,087 NS July 31, 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.03% 41,881 SH Sept. 30, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.03% 16,874 SH Aug. 19, 2026 Daily
IBB · iShares Trust 0.03% 137,423 SH Sept. 11, 2026 Daily
PKW · Invesco Exchange-Traded Fund Trust 0.01% 11,234 SH Oct. 1, 2026 Daily
IWM · iShares Trust 0.01% 504,653 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 9,240 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 111,478 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.01% 56,531 SH Aug. 19, 2026 Daily
DFAS · Dimensional ETF Trust 0.01% 72,399 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 72,279 NS July 31, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.00% 2,221 NS July 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 2,266 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 6,049 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.00% 5,405 SH Sept. 3, 2026 Daily
DFUS · Dimensional ETF Trust 0.00% 5,028 NS July 31, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.00% 24 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 217,490 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 551,839 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 1,428 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 177,609 SH Sept. 11, 2026 Daily

FLGT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 6 analysts SELL
Median target $19.00 -11.5%
0 0.0% Strong Buy
0 0.0% Buy
3 50.0% Hold
1 16.7% Sell
2 33.3% Strong Sell

12-Month Price Target

1 analysts · 2026-10-01

Mean target $19.00 -11.5%

Low$19.00 Mean$19.00 High$19.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
FLGT $816M -84.7 13.8% -18.8% -5.4% 40.6%
CSTL $1.15B -46.9 3.7% -7.0% -5.2% ·
LMRI · · · · · ·
GMRS · · · · · ·
SBC · · · · · ·
NRC · 0.4 -4.0% · · ·
CVS $100.87B 57.1 7.8% 0.44% 2.4% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Jul 30, 2026